Drugs / Levonorgestrel and Ethinyl Estradiol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00685906 Comparator | Apr → Oct 2008 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levonorgestrel and Ethinyl Estradiol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00685906 ↗ |
| Route | Oral | “1 tablet taken by mouth once a day for 28 days per cycle” NCT00685906 ↗ |